CHS win upheld in Pennsylvania hospital sale dispute

The Third Circuit Court of Appeals has upheld a lower court’s ruling that Franklin, Tenn.-based Community Health Systems was in compliance with licensing requirements when it sold Pottstown (Pa.) Hospital to Tower Health.

Advertisement

West Reading, Pa.-based Tower Health sued CHS alleging the for-profit system breached an asset purchase agreement the parties entered into in 2017 for the sale of five Pennsylvania hospitals. Tower alleged that one of those hospitals — Pottstown Hospital — was in a noncompliant condition. 

In 2022, a Pennsylvania federal court ruled after a 19-day trial that the hospital, which was sold in “as is” condition, was “in compliance” with CMS conditions of participation and relevant Pennsylvania licensure requirements prior to the closing of the agreement.

The three-judge appellate court panel unanimously affirmed the Pennsylvania court’s decision Aug. 20. 

“The hospital’s compliant status from 2005 through 2017 bolsters the court’s determination that the evidence did not support Tower’s claim that the fireproofing costs that it ultimately incurred were a ‘liability, indebtedness, commitment, or obligation’ of CHS on the relevant dates,” the appellate court’s ruling said. 

Tower Health did not immediately respond to Becker’s request for comment.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.